Have I got your question right?
By the "current trial" you mean the Covid19/ARDS Phase 2/3??
Will there need to be a cap raise to fund manufacturing costs if the trial goes well?
Holly molly!
If the trial goes well there will be big pharma/bitoech and even nation states galour breaking down the doors to partner with MSB. Perhaps some of them will need to do a cap raise to cover the upfront payments, but I doubt MSB will ever have to worry about capital requirements again except to work out how best to deploy the surplus.
Have I got your question right?By the "current trial" you mean...
-
- There are more pages in this discussion • 16,698 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |